A detailed history of Homestead Advisers Corp transactions in Boston Scientific Corp stock. As of the latest transaction made, Homestead Advisers Corp holds 1,135,826 shares of BSX stock, worth $103 Million. This represents 2.31% of its overall portfolio holdings.

Number of Shares
1,135,826
Previous 1,338,526 15.14%
Holding current value
$103 Million
Previous $103 Million 7.66%
% of portfolio
2.31%
Previous 2.55%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$72.96 - $84.0 $14.8 Million - $17 Million
-202,700 Reduced 15.14%
1,135,826 $95.2 Million
Q2 2024

Jul 23, 2024

SELL
$67.33 - $77.71 $16.2 Million - $18.7 Million
-240,400 Reduced 15.23%
1,338,526 $103 Million
Q1 2024

May 10, 2024

SELL
$57.6 - $68.62 $3.72 Million - $4.43 Million
-64,600 Reduced 3.93%
1,578,926 $108 Million
Q4 2023

Feb 13, 2024

BUY
$48.64 - $57.81 $141,056 - $167,649
2,900 Added 0.18%
1,643,526 $95 Million
Q3 2023

Nov 09, 2023

BUY
$50.19 - $54.68 $1.26 Million - $1.38 Million
25,200 Added 1.56%
1,640,626 $86.6 Million
Q2 2023

Jul 25, 2023

BUY
$49.72 - $54.64 $392,788 - $431,656
7,900 Added 0.49%
1,615,426 $87.4 Million
Q1 2023

Apr 27, 2023

SELL
$45.09 - $50.03 $5.06 Million - $5.61 Million
-112,200 Reduced 6.52%
1,607,526 $80.4 Million
Q4 2022

Feb 03, 2023

SELL
$39.56 - $47.22 $3.86 Million - $4.61 Million
-97,600 Reduced 5.37%
1,719,726 $79.6 Million
Q3 2022

Nov 07, 2022

SELL
$36.71 - $109.66 $154,182 - $460,572
-4,200 Reduced 0.23%
1,817,326 $70.4 Million
Q1 2022

May 12, 2022

BUY
$40.9 - $45.1 $9.91 Million - $10.9 Million
242,400 Added 15.35%
1,821,526 $80.7 Million
Q4 2021

Feb 07, 2022

BUY
$38.07 - $44.87 $11.1 Million - $13.1 Million
291,900 Added 22.68%
1,579,126 $67.1 Million
Q3 2021

Nov 05, 2021

BUY
$41.23 - $45.88 $210,272 - $233,988
5,100 Added 0.4%
1,287,226 $55.9 Million
Q2 2021

Aug 02, 2021

SELL
$38.58 - $44.24 $690,582 - $791,896
-17,900 Reduced 1.38%
1,282,126 $54.8 Million
Q1 2021

May 07, 2021

SELL
$35.27 - $39.67 $2.33 Million - $2.62 Million
-66,000 Reduced 4.83%
1,300,026 $50.2 Million
Q4 2020

Feb 10, 2021

SELL
$33.15 - $41.97 $1.09 Million - $1.39 Million
-33,000 Reduced 2.36%
1,366,026 $49.1 Million
Q3 2020

Nov 13, 2020

SELL
$34.44 - $42.23 $5.37 Million - $6.58 Million
-155,900 Reduced 10.03%
1,399,026 $53.5 Million
Q2 2020

Aug 13, 2020

BUY
$30.19 - $39.11 $63,399 - $82,131
2,100 Added 0.14%
1,554,926 $54.6 Million
Q1 2020

May 14, 2020

SELL
$25.83 - $45.71 $1.16 Million - $2.05 Million
-44,845 Reduced 2.81%
1,552,826 $50.7 Million
Q4 2019

Feb 13, 2020

SELL
$37.87 - $45.37 $576,684 - $690,894
-15,228 Reduced 0.94%
1,597,671 $72.2 Million
Q3 2019

Nov 14, 2019

SELL
$40.31 - $43.45 $2.38 Million - $2.57 Million
-59,101 Reduced 3.53%
1,612,899 $65.6 Million
Q2 2019

Aug 12, 2019

BUY
$34.91 - $42.98 $9.98 Million - $12.3 Million
286,000 Added 20.63%
1,672,000 $71.9 Million
Q1 2019

May 14, 2019

BUY
$32.91 - $40.75 $45.6 Million - $56.5 Million
1,386,000 New
1,386,000 $53.2 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Homestead Advisers Corp Portfolio

Follow Homestead Advisers Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Homestead Advisers Corp, based on Form 13F filings with the SEC.

News

Stay updated on Homestead Advisers Corp with notifications on news.